New article: Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer https://t.co/SBpblqYRfx #breastcancer #oncology https://t.co/X81dwjEnuo
Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer: Background, This study aimed at assessing the safety and immunogenicity of SARS-CoV-2 vaccines in patients, #immunology… https://t.co/j4I
Safety and Immunogenicity of Inactivated and Recombinant Protein SARSCoV2 Vax in Thyroid Cancer.1vax wth 67.0% IgG-positive rate;positivity of SARSCoV2 IgG Ab 96% with 3vax. SARSCoV2 IgG Ab’ positivity 63.0% 2vax CoronaVac or BBIBP-CorV. https://t.co/ltPNd
New Research: Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer: Background This study aimed at assessing the safety and immunogenicity of SARS-CoV-2 vaccines in patients… https://t.co/7o0